Beijing Balance Medical Technology Co

Beijing Balance Medical Technology Co OCF Margin

The Operating Cash Flow Margin of Beijing Balance Medical Technology Co (688198.SS) as of Nov 2, 2026 is 31.89 %. In the previous year, Operating Cash Flow Margin was 27.14 % — a change of 17.50% (higher).

OCF Margin

31.89 %

YoY

17.50%

Last updated:

Operating Cash Flow Margin of Beijing Balance Medical Technology Co is 2025 31.89 % . Operating Cash Flow Margin of Beijing Balance Medical Technology Co was 2024 27.14 % . It decreases by 17.50% higher compared to the previous year.

The Beijing Balance Medical Technology Co OCF Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

OCF Margin
Date
OCF Margin
Jan 1, 2018
48.73 CNY
Jan 1, 2019
43.74 CNY
Jan 1, 2020
27.90 CNY
Jan 1, 2021
30.38 CNY
Jan 1, 2022
43.65 CNY
Jan 1, 2023
38.09 CNY
Jan 1, 2024
27.14 CNY
Jan 1, 2025
31.89 CNY
The Beijing Balance Medical Technology Co OCF Margin history
YEAROCF MarginYoY
31.89 %+17.50%
27.14 %-28.73%
38.09 %-12.75%
43.65 %+43.70%
30.38 %+8.86%
27.90 %-36.21%
43.74 %-10.23%
48.73 %-2.98%
50.23 %-12.56%
57.44 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Beijing Balance Medical Technology Co Stock analysis

What does Beijing Balance Medical Technology Co do? Beijing Balance Medical Technology Co., Ltd. generates revenue through the manufacture and sale of biotechnology products across three key therapeutic areas. The company's heart valve replacement and repair segment offers artificial biological heart valves and valve forming rings, while its congenital heart disease interventional therapy line includes cardiothoracic surgical biological patches, outflow tract single valve patches, and atrial defect occluders. The surgical soft tissue repair division provides neurosurgical biological patches and biological hernia patches. All products are sold primarily within China's domestic market to hospitals and medical institutions seeking advanced cardiovascular and surgical solutions. The firm's product portfolio targets medical professionals specializing in cardiac surgery, congenital heart defect correction, and soft tissue repair procedures. Hospitals and healthcare providers in China purchase these biotechnology solutions for patient treatments, with the domestic market serving as the primary sales channel. The company's focus on specialized medical devices for heart valve procedures, congenital heart conditions, and surgical repair applications drives its revenue streams. Beijing Balance Medical Technology's business model centers on developing and distributing high-precision medical devices tailored to specific surgical needs. The domestic Chinese healthcare system represents the main customer segment, with hospitals and clinics purchasing the company's products for use in cardiac surgeries, congenital heart defect corrections, and soft tissue repair operations. The company's product range directly supports medical procedures requiring biological heart valves, congenital heart disease interventions, and surgical tissue repair solutions. Beijing Balance Medical Technology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Beijing Balance Medical Technology Co stock

Operating Cash Flow Margin of Beijing Balance Medical Technology Co is 31.89 % in 2025.

Operating Cash Flow Margin of Beijing Balance Medical Technology Co changed from 27.14 % to 31.89 %, representing a 17.50% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow Margin Beijing Balance Medical Technology Co since 2006 – with annual values, charts, and detailed analysis.

OCF margin measures the percentage of revenue converted into operating cash flow. It indicates cash generation efficiency from core business operations.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Cash Flow Margin's Beijing Balance Medical Technology Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Operating Cash Flow Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Operating Cash Flow Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Beijing Balance Medical Technology Co

All Key Metrics — Beijing Balance Medical Technology Co